No Detail Found!

Synthesis and dengue inhibition potential of new uridine derivatives: The DENV 2 inhibitors

Author(s)
Sangeeta Vani Alagasamy Faculty of Pharmacy, AIMST University,Bedong, Kedah,Malaysia
Shivkanya Fuloria Faculty of Pharmacy, AIMST University,Bedong, Kedah,Malaysia
Freddy Franklin Department of Medical Microbiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; Department of Parasitology & Department of Medical Microbiology, University Malaya, Kuala Lumpur, Malaysia
Chandramathi Samudi Raju Department of Medical Microbiology, Faculty of Medicine, University of Malaya,Kuala Lumpur,Malaysia
Dharshini Jagadeesan Department of Biotechnology, Faculty of Applied Sciences, AIMST University,Bedong, Kedah,Malaysia
Mohammad Auwal Sa'ad Centre of Excellence for Vaccine Development (CoEVD) & Department of Biotechnology, Faculty of Applied Science, AIMST University,Bedong, Kedah,Malaysia
Ravichandran Veerasamy Faculty of Pharmacy, AIMST University,Bedong, Kedah,Malaysia
Vetriselvan Subramaniyan Pharmacology Unit, Jeffrey Cheah School of Medicine and Health Sciences, MONASH University, Jalan Lagoon Selatan, Bandar Sunway, Petaling Jaya, Selangor, Malaysia
Yuan Seng Wu Centre for Virus and Vaccine Research & Department of Biological Sciences, School of Medical and Life Sciences, Sunway University,Subang Jaya, Selangor,Malaysia
Sundram Karupiah Faculty of Pharmacy, AIMST University,Bedong, Kedah,Malaysia
Neeraj Kumar Fuloria Faculty of Pharmacy, AIMST University, Bedong, Kedah, Malaysia; Center for Transdisciplinary Research, Department of Pharmacology, Saveetha Institute of Medical and Technical Sciences, Saveetha Dental College and Hospital, Saveetha University, Chennai, India
Abstract
Dengue is an important arboviral infection worldwide for which presently there is no specific medicine. Evidence suggests there are four serotypes of dengue virus (DENV1-4), of which DENV 2 is considered to cause the most sever dengue. Therefore, this study was aimed to develop the new uridine derivatives (NUDs) against dengue virus (DENV 2). In current study 2-(3,4-dihydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-4-((substituted cyclohexa-2,5dienylidene)methyl)-1,2,4-triazine-3,5(2H,4H)-dione (2a-f), were obtained via reaction of substituted uridine (1) and different aromatic aldehydes separately. Synthesized NUDs were further characterized using FTIR, 1H & 13C-NMR, mass, and element analysis data. Characterized NUDs were assessed for their inhibition potential against DENV 2. Synthesized NUDs were also evaluated for their cytotoxicity towards Vero cells by MTT assay method. This investigation successfully synthesized NUDs 2a-f and reported their high inhibitory activity against DENV 2. The synthesized NUDs exhibited negligible cytotoxicity. High anti-viral activity against DENV 2 serotype and least/no cytotoxicity of NUDs suggests their importance in the treatment of dengue. Present study recommends that in future these NUDs must be investigated for their clinical importance to establish them as a choice for dengue treatment.
Publication Details
Page(s) 753-759
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 37, Issue: 4, Year: 2024

Request the full text from PASTIC

Keywords
Dengue, Antiviral, nucleoside, DENV 2, enamines, uridine
0

Citations

0

Downloads

75

Views